Solventum Corp reported $13.97B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Abbott USD 86.71B 2.53B Dec/2025
Align Technology USD 6.23B 141K Dec/2025
Baxter International USD 20.06B 1.01B Dec/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Cencora USD 78.36B 1.77B Dec/2025
Dexcom USD 6.34B 1.16B Dec/2025
Insulet USD 3.19B 161.1M Dec/2025
Solventum Corp USD 13.97B 1.1B Sep/2025
West Pharmaceutical Services USD 4.27B 164.2M Dec/2025
Zimmer Biomet Holdings USD 23.09B 396.3M Dec/2025